Ep. 181 - Highlights from ASCO
BioCentury This Week
00:00
Kiskali: A Drug That Reduces Risk of Invasive Disease Recurrence by 25%
Kiskali reduced the risk of invasive disease recurrence by 25% in breast cancer patients. Patients who have lymph node involvement, obviously, often have worse outcomes and maybe in greater need for an adjuvant therapy. The question is whether or not this would actually get approved for that population. This was a study with like 25, 100 patients and 44 were no negative.
Transcript
Play full episode
